Comparison of nephron-protective effects of enalapril and glp analogues (exenatide) in diabetic nephropathy

dc.contributor.authorÇavusoglu T.
dc.contributor.authorErbas O.
dc.contributor.authorKaradeniz T.
dc.contributor.authorAkdemir O.
dc.contributor.authorAcikgoz E.
dc.contributor.authorKaradeniz M.
dc.contributor.authorTuglu M.I.
dc.contributor.authorAtes U.
dc.date.accessioned2025-04-10T11:13:02Z
dc.date.available2025-04-10T11:13:02Z
dc.date.issued2014
dc.description.abstractBackground: One of the major concerns is a nephropathy in diabetes, which applies many different kinds of medicines. However, required level of the treatment of renal disease has not been achieved. Aim: To investigate and compare the effect of the enalapril and the exenatide on diabetic nephropathy in rats developed diabetes by streptozosin. Material and Methods: 32 male Sprague Dawley rats were divided into 4 groups: (1) Control, (2) Diabetic (DM), (3) DM+ Enalapril, and (4) DM+ exenatide groups. Then, the animals were euthanized and their blood samples were collected by cardiac puncture for blood glucose; blood urea nitrogen (BUN), creatinin, and nephrectomy were performed for histopathologic examination, and urine samples were taken on stick for proteinuria. Results: Administration of the enalapril or the exenatide in diabetic rats resulted in a significant reduction both fibronectin, induced nitric oxide synthase (i-NOS) expression in glomerular area and urine protein levels. It was shown that both of enalapril and exenatide protected the renal glomerulus more than diabetic group in the nephropathy histopathologically. Conclusion: The beneficial effects of enalapril and exenatide which reduces fibronectin, i-NOS expression and urine protein levels or increases recovery of glomerules, might be used for preventing the harmful effects of diabetic nephropathy. © 2014 Georg Thieme Verlag KG Stuttgart New York.
dc.identifier.DOI-ID10.1055/s-0034-1372584
dc.identifier.urihttp://hdl.handle.net/20.500.14701/49741
dc.publisherGeorg Thieme Verlag
dc.titleComparison of nephron-protective effects of enalapril and glp analogues (exenatide) in diabetic nephropathy
dc.typeArticle

Files